23andMe: Current personal genomics market leader turned market loser?
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space
img:is([sizes=auto i],[sizes^="auto," i]){contain-intrinsic-size:3000px 1500px} /*# sourceURL=wp-img-auto-sizes-contain-inline-css */
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space